One Step Closer To Tailored Treatment For Lung Cancer

A major study released in the Journal of Clinical Oncology has shown that doctors could increase the survival of patients with a specific type of lung cancer to over 12 months, if they match choice of chemotherapy with the type of tissue in a patient’s tumour. Mick Peake, Lung Cancer Specialist and Chair of the Clinical Reference Group for the UK Lung Cancer Coalition (UKLCC) commented, “This is a very important opportunity to re-assess how we treat people with NSCLC.

More: continued here

Filed under: Lung Cancer on June 10th, 2008